Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Puyu Shi

Overcoming Acquired Resistance to AZD9291, a Third Generation EGFR Inhibitor, Through Modulation of MEK/ERK-dependent Bim and McL-1 Degradation

Clinical Cancer Research

Cancer Research

English

Related publications

MET or NRAS Amplification Is an Acquired Resistance Mechanism to the Third-Generation EGFR Inhibitor Naquotinib

Scientific Reports

Multidisciplinary

English

Molecular Mechanisms of Acquired Resistance to Third-Generation EGFR-TKIs in EGFR T790m-Mutant Lung Cancer

Annals of Oncology

English

Acquired EGFR C797S Mutation Mediates Resistance to AZD9291 in Non–small Cell Lung Cancer Harboring EGFR T790M

Nature Medicine

Molecular Biology

English

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

Journal of Thoracic Oncology

Respiratory Medicine

English

WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors

Laboratory Investigation

Forensic Medicine

Molecular Biology

English

NDRG2 Contributes to Cisplatin Sensitivity Through Modulation of BAK-to-Mcl-1 Ratio

Cell Death and Disease

Molecular Neuroscience

Cancer Research

English

PAK Signaling Promotes Acquired Resistance to BRAF and MEK Inhibitors

Cancer Discovery

English

RASSF1A Mediates P21Cip1/Waf1-Dependent Cell Cycle Arrest and Senescence Through Modulation of the Raf-Mek-Erk Pathway and Inhibition of Akt

Cancer Research

Cancer Research

English

Phenylethyl Isothiocyanate Reverses Cisplatin Resistance in Biliary Tract Cancer Cells via Glutathionylation-Dependent Degradation of McL-1

English